A detailed history of Credit Agricole S A transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Credit Agricole S A holds 79,952 shares of VRTX stock, worth $36.3 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
79,952
Previous 48,593 64.53%
Holding current value
$36.3 Million
Previous $20.3 Million 84.5%
% of portfolio
0.21%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $12.3 Million - $15.2 Million
31,359 Added 64.53%
79,952 $37.5 Million
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $6.79 Million - $7.43 Million
16,663 Added 52.19%
48,593 $20.3 Million
Q4 2023

Feb 13, 2024

BUY
$343.0 - $410.68 $6.14 Million - $7.35 Million
17,899 Added 127.57%
31,930 $13 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $3.42 Million - $3.67 Million
-10,127 Reduced 41.92%
14,031 $4.88 Million
Q2 2023

Jul 31, 2023

SELL
$314.42 - $351.91 $179,848 - $201,292
-572 Reduced 2.31%
24,158 $8.5 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $579,205 - $660,739
-2,045 Reduced 7.64%
24,730 $7.79 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $3.89 Million - $4.38 Million
13,618 Added 103.5%
26,775 $7.73 Million
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $2.95 Million - $3.29 Million
10,763 Added 449.58%
13,157 $3.81 Million
Q2 2022

Aug 08, 2022

BUY
$234.96 - $292.55 $398,962 - $496,749
1,698 Added 243.97%
2,394 $675,000
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $11,071 - $13,048
-50 Reduced 6.7%
696 $181,000
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $525,124 - $587,656
-2,895 Reduced 79.51%
746 $135,000
Q2 2021

Aug 10, 2021

BUY
$187.49 - $221.1 $542,033 - $639,200
2,891 Added 385.47%
3,641 $734,000
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $2.37 Million - $2.76 Million
-11,430 Reduced 93.84%
750 $161,000
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $2.49 Million - $3.33 Million
12,046 Added 8989.55%
12,180 $2.88 Million
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $8,692 - $10,305
34 Added 34.0%
134 $36,000
Q2 2020

Aug 13, 2020

SELL
$225.48 - $295.8 $22,548 - $29,580
-100 Reduced 50.0%
100 $29,000
Q1 2019

May 14, 2019

BUY
$163.73 - $194.7 $32,745 - $38,940
200 New
200 $37,000
Q4 2017

Feb 13, 2018

SELL
$137.28 - $155.55 $8.44 Million - $9.56 Million
-61,479 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $673,398 - $737,543
4,546 Added 7.98%
61,479 $9.35 Million
Q2 2017

Aug 14, 2017

BUY
N/A
56,933
56,933 $7.34 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.